According to Dr. Cameron Carter, Editor
of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, the study is an important example
of how more
sophisticated approaches to analyzing brain imaging data examining transitions between mental states over time can
measure altered brain dynamics that can identify subtle
risk states or even track the transition from subclinical to clinical psychopathology.
Where I think you see more
of that kind
of risk is in mid-size companies that are growing but haven't put
sophisticated measures in place to monitor things like who, exactly, they're doing business with.